$BMRN BIOMARIN PHARMACEUTICAL INC Insider Trading Week 19/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC in week 19/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Payment of Exercise | F | 57.44 | 1,096 | 62,954 | 21,984 | 23.1 K to 22 K (-4.75 %) |
| May 16 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 57.44 | 207 | 11,890 | 8,290 | 8.5 K to 8.3 K (-2.44 %) |
| May 16 2014 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Payment of Exercise | F | 57.44 | 1,241 | 71,283 | 63,126 | 64.4 K to 63.1 K (-1.93 %) |
| May 16 2014 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 49.50 | 94 | 4,653 | 64,367 | 64.3 K to 64.4 K (+0.15 %) |
| May 14 2014 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 58.23 | 1,434 | 83,498 | 64,850 | 66.3 K to 64.9 K (-2.16 %) |
| May 14 2014 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 59.30 | 1,566 | 92,864 | 66,284 | 67.9 K to 66.3 K (-2.31 %) |
| May 14 2014 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Payment of Exercise | F | 59.30 | 1,096 | 64,993 | 57,864 | 59 K to 57.9 K (-1.86 %) |
| May 14 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 59.30 | 4,567 | 270,823 | 185,189 | 189.8 K to 185.2 K (-2.41 %) |
| May 14 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 59.30 | 282 | 16,723 | 8,497 | 8.8 K to 8.5 K (-3.21 %) |
| May 14 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Sell | S | 58.18 | 478 | 27,809 | 23,080 | 23.6 K to 23.1 K (-2.03 %) |
| May 14 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Payment of Exercise | F | 59.30 | 522 | 30,955 | 23,558 | 24.1 K to 23.6 K (-2.17 %) |
| May 13 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Sell | S | 57.96 | 621 | 35,992 | 24,080 | 24.7 K to 24.1 K (-2.51 %) |
| May 12 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 56.78 | 5,479 | 311,098 | 189,756 | 195.2 K to 189.8 K (-2.81 %) |
| May 12 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 29.69 | 715 | 21,228 | 195,235 | 194.5 K to 195.2 K (+0.37 %) |
| May 12 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Payment of Exercise | F | 56.78 | 679 | 38,554 | 24,701 | 25.4 K to 24.7 K (-2.68 %) |
| May 12 2014 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Payment of Exercise | F | 56.78 | 1,696 | 96,299 | 58,960 | 60.7 K to 59 K (-2.80 %) |
| May 12 2014 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Grant | A | 29.69 | 704 | 20,902 | 61,360 | 60.7 K to 61.4 K (+1.16 %) |
| May 12 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Grant | A | 29.69 | 498 | 14,786 | 8,779 | 8.3 K to 8.8 K (+6.01 %) |
| May 12 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 56.78 | 444 | 25,210 | 8,281 | 8.7 K to 8.3 K (-5.09 %) |
| May 12 2014 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 57.91 | 3,479 | 201,474 | 67,850 | 71.3 K to 67.9 K (-4.88 %) |
| May 12 2014 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 56.78 | 2,521 | 143,142 | 71,329 | 73.9 K to 71.3 K (-3.41 %) |